Flexeril: Directly Online Now - in the UK

Quick a general overview

The active molecule in this class is cyclobenzaprine, marketed in some countries under the brand name Flexeril. Extended-release versions exist under different trade names in certain regions.

Classification: a centrally acting skeletal muscle relaxant with structural resemblance to tricyclic antidepressants. It is intended for short-term use as part of a broader strategy that includes rest, physiotherapy and local measures such as heat or cold packs. See When it is used and Dose delivery and administration details are available.

Common oral formulations internationally include immediate-release tablets (5 mg and 10 mg) and extended-release preparations (for example 15 mg and 30 mg). Note that cyclobenzaprine is not commonly licensed in the UK; see Regulations of the United Kingdom and access for how it may be obtained.

Mechanism by which the drug acts

Rather than acting directly on muscle fibers, cyclobenzaprine exerts its effect within the central nervous system. It reduces excess somatic motor activity at the level of the brainstem, which can ease involuntary muscle contractions coupled with the pain they cause.

Because the molecule is related to tricyclic antidepressants, anticholinergic effects and cardiac people relating to one another potential exist. Sedation is a common contributor to symptomatic improvement. Assessing the the story of the people relating to one another in the documentation. Medicament the dynamic of social contacts with others are the core of collaboration..

When it gets put to use

Cyclobenzaprine is prescribed as an add-on for short-term symptomatic relief of acute musculoskeletal pain associated with muscle spasm, for example after a sprain, strain or episode of back spasm. It is intended to be combined with non-drug measures, such as graded activity and targeted physiotherapy.

This agent is not the right choice for long-term spasticity management in neurological conditions such as multiple sclerosis or cerebral palsy; other medicines are preferred in those situations. See Comparative review of alternate options in the options menu.

The dose and administration process

Always follow the directions on your prescription label or the instructions given by your clinician. Typical immediate-release regimens used where available start at 5 mg three times daily and may be increased to 10 mg three times daily if required and tolerated. Extended-release products are usually taken once daily at strengths such as 15 mg or 30 mg.

Treatment is generally limited to about two to three weeks. Do not continue the medicine longer than advised without a clinical review.

• Elderly patients and people with hepatic impairment should begin at a reduced dose and be observed closely because clearance may be slower and sensitivity higher.
• The medicine may be taken with or without food; if it causes stomach upset try taking it with a meal.
• If you miss your dose, follow the guidance in Dose not given care plan. Do not take two doses at once to compensate for a dose was skipped.

If you experience marked drowsiness, dizziness or visual disturbance, avoid driving or using machinery until those effects have passed. Guidance about driving while on medicines is available under UK regulatory requirements for businesses and access.

Warning bulletins, cautions, and advisories

Before the start cyclobenzaprine, tell your prescriber if you have any of the following conditions:

• Reduced liver function or known liver disease
• Glaucoma or history of raised intraocular pressure
• Problems with urinary retention or an enlarged prostate
• A history of heart disease, rhythm problems or heart failure

The phase of pregnancy and lactation: human data are limited. Use only after discussing the balance of risks and benefits with your healthcare professional.

The medicine commonly causes drowsiness and will increase impairment if combined with alcohol or other sedatives. There is also a risk of serotonin syndrome when cyclobenzaprine is combined with serotonergic drugs. See Undesired effects and Reciprocal the process of people engagings are not just about words, but meaning. between medicines.

Conditions that rule out its use

Do not take cyclobenzaprine if any of the following apply to you:

• Untreated or severe hyperthyroidism
• Recovery phase following a recent myocardial infarction, existing heart block, clinically significant arrhythmias or severe heart failure
• Concurrent or recent (within 14 days) treatment with a monoamine oxidase inhibitor (for example phenelzine, tranylcypromine, selegiline) or use of linezolid

Combining MAO inhibitors and cyclobenzaprine can trigger life-threatening reactions. If in doubt, contact your prescriber before taking this medicine. See Medicinal product user the act of connecting with otherss drive engagement and learning. for more information, consult the documentation.

Unwanted effects

Stop the medicine and seek immediate emergency care if you develop signs of an allergic reaction such as hives, facial or throat swelling, or difficulty breathing.

Contact urgent medical services if you experience any of:

• Fast, pounding or irregular heartbeat, or chest pain
• Sudden weakness on one side of the body, difficulty speaking, sudden confusion or loss of coordination

Symptoms of serotonin syndrome include agitation, confusion, hallucinations, high fever, sweating, shivering, tremor, muscle stiffness or twitching, fast heart rate, nausea, vomiting or diarrhea. Seek immediate medical attention if these signs appear.

Routine, usually mild adverse impact on health include:

• Drowsiness, fatigue or lightheadedness
• A parched oral cavity and constipation as a pair
• Migraine or blurred vision

If possible side effects persist or interfere with daily life, speak to your prescriber about nontraditional treatments. See Other options merged with their comparisons.

Alerts for drug a reciprocal exchange checks

Cyclobenzaprine increases sedation when combined with other central nervous system depressants. Before you embark this medicineperform a review all prescription drugs, over-the-counter products and herbal supplements in meeting with your clinician.

• Opioids, benzodiazepines and some other muscle relaxants can increase drowsiness in conjunction with the risk of respiratory depression.
• Some antihistamines and sleep aids add to sedation.
• Serotonergic agents (SSRIs, SNRIs, TCAs, tramadol, certain migraine drugs), linezolid, methylene blue and St John’s wort can raise the chance of serotonin syndrome when used with cyclobenzaprine.
• MAO inhibitors are contraindicated within 14 days of cyclobenzaprine; see Contrasuggestions.
• Strong inhibitors of CYP1A2 (for example fluvoxamine or ciprofloxacin) and some CYP3A4 or CYP2D6 inhibitors may increase cyclobenzaprine exposure and negative outcomes.
• Drugs that affect cardiac conduction or that prolong the QT interval may add to arrhythmia risk when combined with cyclobenzaprine.

Keep an up-to-date list of medicines and share it with any clinician who is treating you.

Steps to take after missing a dose

As soon as you miss a dose, take it as soon as you remember unless the next dose is due shortly. If it is nearly time for the next scheduled dose, skip the i skipped the dose and continue as normal. Do not administer two doses at once to make up for a i skipped the dose.

Exceeding a safe dose

If you suspect an overdosing, dial emergency services without delay. Signs of overdosing may include extreme drowsiness, repeated vomiting, rapid heart rate, tremor, severe agitation, confusion or hallucinations. Large overdosings can be life threatening and require urgent hospital treatment.

Storage infrastructure and disposal logistics

Store medicines at room temperature, ideally between 15 to 30 degrees C (59 to 86 degrees F). Keep tablets in a tightly closed container, dry and out of reach and sight of children and pets. Do not use beyond the expiry date indicated on the packaging.

Return unused or expired medicines to a pharmacy take-back scheme when available. Do not dispose of medicines down the toilet unless the label or leaflet tells you to do so.

A selection of exploring other possibilities and contrasts

In the UK, clinicians commonly use several other muscle relaxants and non-drug approaches. The choice depends on the cause of muscle symptoms, other medical conditions and how well undesired reactions are tolerated.

• Baclofen: commonly used for spasticity; can cause drowsiness and should be tapered when stopping after prolonged use.
• Tizanidine forms include capsules and tablets: useful for spasm and spasticity; may lower blood pressure and often requires liver surveillance of system activity.
• Methocarbamol: centrally acting, used for short-term relief of acute muscle spasm; sedation is frequent.
• Diazepam: a benzodiazepine with muscle relaxant properties; effective for brief courses but carries a risk of dependence.
• Dantrolene: acts peripherally on muscle; used for certain chronic spasticity states and in malignant hyperthermia; liver the act of monitoring is often needed.

Non-pharmacological measures such as early guided mobilization, targeted physiotherapy, simple analgesics or NSAIDs (if appropriate), ergonomic adjustments and heat or cold remain central to management. For regulatory and cost issues see British regulatory framework and access and Price trends in the United Kingdom (2026).

Price trends in the United Kingdom (2026)

The figures below are approximate private prices for planning only. Actual charges vary by pharmacy, pack size and whether an item is supplied on the NHS or as an unlicensed import. These are typical private costs seen in 2026.

• Cyclobenzaprine (Flexeril): not routinely licensed in the UK. If obtained as an unlicensed special or via private import expect substantially higher costs than common generics. Private per-tablet prices can range from about 1 to 3 pounds for some strengths, plus import and handling fees. Many UK pharmacies will not supply it.
• Baclofen (generic): roughly 0.10 to 0.25 pounds per 10 mg tablet on private purchase, depending on quantity and supplier.
• Tizanidine therapy (generic): commonly about 0.10 to 0.30 pounds per 2 mg tablet when sourced privately.
• Methocarbamol (generic): private prices often range from 0.15 to 0.50 pounds per 750 mg tablet.
• Diazepam (generic): usually low unit cost (often a few pence per 2 mg tablet) but subject to controlled drug prescribing rules and dispensing restrictions.
• Dantrolene (generic): typically more expensive than baclofen or tizanidine; prices vary widely by brand and strength.

In England a standard NHS prescription charge applies per item (indicative figure about 9.a weight of 90 pounds in 2026 Scotland, Wales and Northern Ireland have free prescription services. Unlicensed specials and private prescriptions fall outside NHS arrangements and can be substantially more expensive than NHS-dispensed generics.

UK specified regulations and access

• Licensing: cyclobenzaprine is not commonly licensed in the UK. Under the Human Medicines Regulations 2012 a UK prescriber may supply an unlicensed medicine when they judge it necessary and accept responsibility for its use.
• Prescription status: most muscle relaxants for acute spasm are Prescription Only Medicines and must be supplied by a UK-registered prescriber and a pharmacy regulated by the General Pharmaceutical Council (GPhC).
• Online pharmacies: use only UK-regulated online services. Check for GPhC registration and verify the pharmacy on the official register. Avoid unregulated websites and overseas sellers that do not meet UK standards.
• Personal importation: bringing prescription medicines into the UK is restricted. Medicines that are unlicensed or not compliant with UK rules may be seized. Controlled drugs face stricter import controls. Seek advice from a pharmacist or the Medicines and Healthcare products Regulatory Agency (MHRA) before attempting to import medicines.
• Driving and impairment: driving while impaired by a medicine is an offence. Cyclobenzaprine can cause drowsiness and dizziness. Do not drive until you know how the medicine affects you and follow your prescriber's advice.
• Use in pregnancy and children: medicines should be used following individualized risk-benefit assessment. Extra caution is required for pregnancy, breastfeeding and paediatric prescribing.

For information on licensed other selections and expected costs see Alternative routes and comparisons and Costs in the United Kingdom (2026).

Quick Reference FAQs

Does the NHS stock cyclobenzaprine? Because it is rarely licensed in the UK, routine NHS supply is uncommon. A prescriber may arrange an unlicensed special for selected patients in exceptional circumstances. See UK administrative regulations and access.

How soon does it start to work? Some patients notice sedation and partial relief within hours; meaningful benefit for acute spasm is often apparent within the first few days when the medicine is combined with rest and physiotherapy. Refer to Appendix A Dose timing and administration for recommended durations.

Is it okay to drink alcohol when I am taking this prescription? Choose non-alcoholic beverages. Alcoholic drink product plus cyclobenzaprine can worsen sedation and impair coordination. See Drug mutual interaction potential for other combinations to avoid.

Main notes to remember

This page is intended for general educational purposes and does not replace personalised medical advice. Always follow instructions from your prescriber or pharmacist. If you develop serious symptoms or suspect a severe reaction, seek emergency medical help immediately.